Infectious Diseases and Clinical Microbiology

Prof. Dr. Serap Gençer

Doctor and researcher Acıbadem Maslak Hastanesi İstanbul
BrucellosisHIV InfectionsBacteremiaEscherichia coli InfectionsStaphylococcal InfectionsInfluenza, HumanCOVID-19Tuberculosis, MeningealTuberculosis, Pulmonary
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Brucellosis 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • HIV Infections 3 publications
  • Bacteremia 2 publications
  • Escherichia coli Infections 2 publications
  • Staphylococcal Infections 2 publications
  • Influenza, Human 2 publications
  • COVID-19 2 publications
  • Tuberculosis, Meningeal 2 publications
  • Tuberculosis, Pulmonary 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Cinsel Yolla Bulaşan Hastalıklar
  • Alt Solunum Yolları Enfeksiyonu (Bronşit, Zatürre -Pnömoni)
  • Bulaşıcı Hastalıklar
  • Hepatit Hastalıkları
  • HIV ve AIDS
  • Cilt, Doku ve Yara Enfeksiyonları (Zona, Döküntüler, Diyabetik Ayak ve Cerrahi Yara Enfeksiyonları)
  • Erişkin Aşılamaları
  • Alt Solunum Yolları Enfeksiyonu
  • Cilt Enfeksiyonları

CV

Education and experience

From source

Experience

  • 2018Acıbadem Sağlık Grubuacibadem.com.tr

Education

  • 1998Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji, Uzmanlıkacibadem.com.tr
  • 1992Marmara Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologyacibadem.com.trFrom source
  • InstitutionAcıbadem Maslak Hastanesiacibadem.com.trFrom source
  • Area of workBrucellosisExtracted from 4 publications · Model version —From source
  • Publications79 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-3217-6305ORCIDFrom source
  • Last synchronised4 November 2026 20:44https://www.acibadem.com.tr/doktor/serap-gencer/acibadem.com.tr

Scientific work

Publications on Brucellosis

79 publications

  1. HIV Testing and Diagnosis Rates in Relation to HIV Indicator Conditions: A Multicenter Retrospective Analysis from Turkey

    Current HIV Research, 2026

    DOI 10.2174/011570162x441105260313062736 Source: ORCID

  2. Prospective screening for carbapenemase-producing gram-negative bacteria in rectal swabs of ICU patients

    Annals of Clinical and Analytical Medicine, 2026

    DOI 10.4328/acam.22809 Open-access full textSource: ORCID

  3. Influenza, COVID-19, and pneumococcal vaccination status among adults in Türkiye ​

    Turkish Journal of Medical Sciences, 2026

    DOI 10.55730/1300-0144.6368 PMID 42676985 Open-access full textSource: ORCID

  4. A hidden pathogen in routine cultures: Recurrent bilateral breast abscesses caused by Corynebacterium kroppenstedtii

    Diagnostic Microbiology and Infectious Disease, 2026

    DOI 10.1016/j.diagmicrobio.2026.117548 PMID 42579902 Source: OpenAlex

  5. Evaluation of Triglyceride-Glucose (TyG) index in individuals living with HIV under antiretroviral therapy (ART)

    BMC Infectious Diseases, 2025

    DOI 10.1186/s12879-025-12011-0 PMID 41225418 Open-access full textSource: ORCID

  6. Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-77259-z PMID 39487308 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region

    Antibiotics, 2024

    DOI 10.3390/antibiotics13100990 PMID 39452256 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Ceftazidime-Avibactam versus Polymyxin-Based Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48 Endemic Region

    Journal of Global Antimicrobial Resistance, 2024

    DOI 10.1016/j.jgar.2024.10.005 Open-access full textSource: OpenAlex

  9. Registry-Based Retrospective Cohort Study of Mortality among Adults Admitted to Intensive Care Units in Istanbul with Hospital Acquired Pseudomonas aeruginosa Bloodstream-Infection between 2014–2021

    Antibiotics, 2024

    DOI 10.3390/antibiotics13010090 PMID 38247649 6 citations (Europe PMC) Open-access full textSource: ORCID

  10. Clinical efficacy and safety of prolonged versus intermittent administration of antipseudomonal beta-lactam antibiotics in adults with severe acute infections: A meta-analysis of randomized controlled trials

    Journal of Infection and Chemotherapy, 2023

    DOI 10.1016/j.jiac.2023.05.008 PMID 37169223 5 citations (Europe PMC) Source: ORCID

View all 79 publications